315 related articles for article (PubMed ID: 20547424)
1. Comparison of paroxetine and amitriptyline as adjunct to lithium maintenance therapy in bipolar depression: a reanalysis of a randomized, double-blind study.
Pilhatsch M; Wolf R; Winter C; Lewitzka U; Bauer M
J Affect Disord; 2010 Nov; 126(3):453-7. PubMed ID: 20547424
[TBL] [Abstract][Full Text] [Related]
2. Does tachyphylaxis occur after repeated antidepressant exposure in patients with Bipolar II major depressive episode?
Amsterdam JD; Shults J
J Affect Disord; 2009 May; 115(1-2):234-40. PubMed ID: 18694599
[TBL] [Abstract][Full Text] [Related]
3. Lithium but not carbamazepine augments antidepressant efficacy of mirtazapine in unipolar depression: an open-label study.
Schüle C; Baghai TC; Eser D; Nothdurfter C; Rupprecht R
World J Biol Psychiatry; 2009; 10(4 Pt 2):390-9. PubMed ID: 18609420
[TBL] [Abstract][Full Text] [Related]
4. Algorithms for the pharmacotherapy of bipolar disorder.
Motohashi N
Psychiatry Clin Neurosci; 1999 Oct; 53 Suppl():S41-4. PubMed ID: 10560897
[TBL] [Abstract][Full Text] [Related]
5. [A double-blind comparative study of the effectiveness and tolerance of paroxetine and amitriptyline in treatment of breast cancer patients with clinically assessed depression].
Möslinger-Gehmayr R; Zaninelli R; Contu A; Oberhoff C; Gutschow K; Schindler AE; Staab HJ
Zentralbl Gynakol; 2000; 122(4):195-202. PubMed ID: 10795116
[TBL] [Abstract][Full Text] [Related]
6. A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II).
McElroy SL; Weisler RH; Chang W; Olausson B; Paulsson B; Brecher M; Agambaram V; Merideth C; Nordenhem A; Young AH;
J Clin Psychiatry; 2010 Feb; 71(2):163-74. PubMed ID: 20122366
[TBL] [Abstract][Full Text] [Related]
7. Neuroleptic malignant syndrome and lithium carbonate.
Fava S; Galizia AC
J Psychiatry Neurosci; 1995 Jul; 20(4):305-6. PubMed ID: 7647084
[TBL] [Abstract][Full Text] [Related]
8. Serotonin syndrome after lithium add-on medication to paroxetine.
Sobanski T; Bagli M; Laux G; Rao ML
Pharmacopsychiatry; 1997 May; 30(3):106-7. PubMed ID: 9211572
[TBL] [Abstract][Full Text] [Related]
9. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
Hantouche EG; Akiskal HS; Lancrenon S; Chatenêt-Duchêne L
J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
[TBL] [Abstract][Full Text] [Related]
10. Double-blind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania.
Amrollahi Z; Rezaei F; Salehi B; Modabbernia AH; Maroufi A; Esfandiari GR; Naderi M; Ghebleh F; Ahmadi-Abhari SA; Sadeghi M; Tabrizi M; Akhondzadeh S
J Affect Disord; 2011 Mar; 129(1-3):327-31. PubMed ID: 20843556
[TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care.
Wade A; Crawford GM; Angus M; Wilson R; Hamilton L
Int Clin Psychopharmacol; 2003 May; 18(3):133-41. PubMed ID: 12702891
[TBL] [Abstract][Full Text] [Related]
12. Cerebellar ataxia in upper limbs triggered by addition of carbamazepine to lithium treatment.
Manto MU; Jacquy J; Hildebrand J
Acta Neurol Belg; 1996 Dec; 96(4):316-7. PubMed ID: 9008782
[No Abstract] [Full Text] [Related]
13. [Bradycardia after beginning therapy with metoprolol and paroxetine].
König F; Häfele M; Hauger B; Löble M; Wössner S; Wolfersdorf M
Psychiatr Prax; 1996 Sep; 23(5):244-5. PubMed ID: 8992519
[TBL] [Abstract][Full Text] [Related]
14. Monotherapy versus combined treatment with second-generation antipsychotics in bipolar disorder.
Ketter TA
J Clin Psychiatry; 2008; 69 Suppl 5():9-15. PubMed ID: 19265635
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of two treatment algorithms in bipolar depression consisting of a combination of lithium, lamotrigine or placebo and paroxetine.
van der Loos ML; Mulder P; Hartong EG; Blom MB; Vergouwen AC; van Noorden MS; Timmermans MA; Vieta E; Nolen WA;
Acta Psychiatr Scand; 2010 Sep; 122(3):246-54. PubMed ID: 20136801
[TBL] [Abstract][Full Text] [Related]
16. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.
Calabrese JR; Bowden CL; Sachs G; Yatham LN; Behnke K; Mehtonen OP; Montgomery P; Ascher J; Paska W; Earl N; DeVeaugh-Geiss J;
J Clin Psychiatry; 2003 Sep; 64(9):1013-24. PubMed ID: 14628976
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome of bipolar depressed patients receiving lamotrigine as add-on to lithium with the possibility of the addition of paroxetine in nonresponders: a randomized, placebo-controlled trial with a novel design.
van der Loos ML; Mulder P; Hartong EG; Blom MB; Vergouwen AC; van Noorden MS; Timmermans MA; Vieta E; Nolen WA;
Bipolar Disord; 2011 Feb; 13(1):111-7. PubMed ID: 21320258
[TBL] [Abstract][Full Text] [Related]
18. Induction of a mixed depressive episode during rTMS treatment in a patient with refractory major depression.
Rachid F; Golaz J; Bondolfi G; Bertschy G
World J Biol Psychiatry; 2006; 7(4):261-4. PubMed ID: 17071547
[TBL] [Abstract][Full Text] [Related]
19. Predictors of efficacy in lithium augmentation for treatment-resistant depression.
Sugawara H; Sakamoto K; Harada T; Ishigooka J
J Affect Disord; 2010 Sep; 125(1-3):165-8. PubMed ID: 20089312
[TBL] [Abstract][Full Text] [Related]
20. Selecting appropriate treatments for maintenance therapy for bipolar disorder.
Thase ME
J Clin Psychiatry; 2008; 69 Suppl 5():28-35. PubMed ID: 19265638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
